Business Information
The group's principal activity is to design, develop and market products for the surgical treatment of spine disorders. The group's principal product offering includes a minimally invasive surgical platform called maximum access surgery (mas), as well as classic fusion products. Mas combines three of its current product offerings-neurovision, a proprietary software-driven nerve avoidance system, maxcess, a split blade-design minimally invasive surgical system and specialized implants-that collectively minimize soft tissue disruption during spine surgery. It provides a surgeon with enhanced visibility and access to the spine for fusion. The group's also offers a portfolio of classic fusion products, including spine allografts and spine implants such as rods, plates and screws that are necessary for a variety of spine surgery procedures. The group became publicly held on 12-May-2004.
|
|
Name |
Title
|
Email
|
| Alexis Lukianov | Chmn., CEO | N/A | | Keith Valentine | COO, Pres. | N/A | | Bryan Cornawall | VP - Research, Clinical Resources | N/A | | Jason Hannon | Sr. VP, General Counsel | N/A | | Jeffrey Rydin | Sr. VP - US Sales | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 98,091 | (47,910) | | 2005 | 61,789 | (30,339) | | 2004 | 38,403 | (14,210)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
